Breast reconstruction is the surgical method of reconstructing the shape and looks of a breast, most generally in women who have had surgery to treat breast cancer. It includes autologous tissue, prosthetic implants, or a mixture of both, to reconstruct a natural-looking breast. Breast reconstruction techniques have developed over the last numerous decades, with options tailored to the individual needs of women with breast cancer.
Thus, the high prevalence of breast cancer is expected to create a significant demand for breast reconstruction in the coming years, which is further anticipated to drive the breast reconstruction market.
Countries in Brazil and Argentina are among the top destinations in the world for aesthetic procedures. However, the outbreak of COVID–19 has severely impacted the flow of medical services in the region. In addition, the countries are famous for medical tourism, which is also affected by the pandemic. Brazil, Argentina, Peru, Chile, Uruguay, Colombia are affected by the second wave of corona infection. Among which Brazil has registered the majority of the deaths. As of May 2021, around 411,854 lives have already been lost in Brazil, which is a sign of the second wave of COVID19 infection. The regular practice is more complex where rates of immediate breast reconstruction (IBR) pre-COVID-19 were high; Brazil's overall breast reconstruction rates were 29% before the pandemic, higher than recorded in the UK National Mastectomy and Breast Reconstruction Audit (21%). However, the COVID-19 specific guidelines issued by the Association of Breast Surgery in the UK in 2020 dramatically changed IBR. Approximately 30% reported a continuation of the practice during the pandemic. Even with these difficulties resulting from the pandemic, options were acknowledged to maintain institutional features. Nevertheless, it is expected that the region is likely to impose a second lockdown, which will eventually hamper the healthcare industry in the area. Moreover, countries are significantly dependent on the US and European countries for their medical resources. Thus, the market in the region has experienced a significant slowdown and is expected to face the same in the following two to three years.
Strategic insights for the South and Central America Breast Reconstruction provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 31.2 Million |
Market Size by 2028 | US$ 46.3 Million |
Global CAGR (2021 - 2028) | 5.8% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Technology
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
The geographic scope of the South and Central America Breast Reconstruction refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The Breast reconstruction market in South and Central America is expected to grow from US$ 31.2 million in 2021 to US$ 46.3 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2021 to 2028. Patients undergoing unilateral or bilateral mastectomy procedures usually opt for breast reconstruction for regaining the original shape of the breasts and improving their aesthetic appeal, among other factors. Thus, it is important for the market players to come up with innovative products that would marginally boost the adoption of this procedure. Tissue expander is one such innovation that eases the task of surgeons and improves the effectiveness of the reconstruction procedures. Moreover, in September 2020, POLYTECH Health & Aesthetics GmbH announced the launch of its expanded B-Lite portfolio, which is consists of the world's first and only lightweight breast implants. Thus, the capitalization in innovative technologies to come up with breakthrough products is emerging a s key opportunity for the breast construction market players to secure high revenues and marginal profits in the coming years.
In terms of technology, the inframammary segment accounted for the largest share of the South and Central America breast reconstruction market in 2020. In terms of type, the breast implants segment accounted for the largest share of the South and Central America breast reconstruction market in 2020. In terms of placement, the dual plane insertion segment accounted for the largest share of the South and Central America breast reconstruction market in 2020. In terms of procedure, the immediate procedures segment held a larger market share of the breast reconstruction market in 2020.
A few major primary and secondary sources referred to for preparing this report on the breast reconstruction market in South and Central America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Allergan Plc
By Technology
By Type
By Placement
By Procedure
By Country
The South and Central America Breast Reconstruction Market is valued at US$ 31.2 Million in 2021, it is projected to reach US$ 46.3 Million by 2028.
As per our report South and Central America Breast Reconstruction Market, the market size is valued at US$ 31.2 Million in 2021, projecting it to reach US$ 46.3 Million by 2028. This translates to a CAGR of approximately 5.8% during the forecast period.
The South and Central America Breast Reconstruction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Breast Reconstruction Market report:
The South and Central America Breast Reconstruction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Breast Reconstruction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Breast Reconstruction Market value chain can benefit from the information contained in a comprehensive market report.